Prognostic importance of the neutrophil-to-lymphocyte ratio in malignant peritoneal mesothelioma patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

被引：0
|
作者：
Zhang Xinjing [1 ]
Gong Lei [2 ]
Li Xinbao [1 ]
Ji Zhonghe [1 ]
Yang Zhiran [1 ]
Gao Chao [1 ]
Zhang Kai [1 ]
Yan Lijun [1 ]
Yan Guojun [1 ]
Yu Junhui [1 ]
Zhang Yanbin [1 ]
An Songlin [1 ]
机构：
[1] Capital Medical University,Department of peritoneal surface surgical oncology, Beijing Shijitan Hospital
[2] Capital Medical University,Department of hepatobiliary surgical oncology, Beijing Shijitan Hospital
来源：
BMC Cancer | / 25卷 / 1期
关键词：
Prognosis; Neutrophil-to-Lymphocyte Ratio; Malignant Peritoneal Mesothelioma; Cytoreductive Surgery; Hyperthermic Intraperitoneal Chemotherapy;
D O I：
10.1186/s12885-025-13606-1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations
    Enomoto, Laura M.
    Shen, Perry
    Levine, Edward A.
    Votanopoulos, Konstantinos I.
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4231 - 4241
  • [42] Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: Results of a prospective study
    Brigand, C
    Monneuse, O
    Mohamed, F
    Sayag-Beaujard, AC
    Isaac, S
    Gilly, FN
    Glehen, O
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (03) : 405 - 412
  • [43] Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion
    Deraco, M
    Nonaka, D
    Baratti, D
    Casali, P
    Rosai, J
    Younan, R
    Salvatore, A
    Cabras, AD
    Kusamura, S
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 229 - 237
  • [44] Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion
    Marcello Deraco
    Daisuke Nonaka
    Dario Baratti
    Paolo Casali
    Juan Rosai
    Rami Younan
    Andreola Salvatore
    Antonello D. Cabras AD
    Shigeki Kusamura
    Annals of Surgical Oncology, 2006, 13 : 229 - 237
  • [45] Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis
    Nesher, Eviatar
    Greenberg, Ron
    Avital, Shmuel
    Skornick, Yehuda
    Schneebaunn, Schlomo
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (11): : 787 - 790
  • [46] Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Sarcomatosis
    Randle, Reese W.
    Swett, Katrina R.
    Shen, Perry
    Stewart, John H.
    Levine, Edward A.
    Votanopoulos, Konstantinos I.
    AMERICAN SURGEON, 2013, 79 (06) : 620 - 624
  • [47] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
    Khan, Hadi M.
    Hanif, Hamza
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (02): : 259 - 261
  • [48] Peritoneal sarcomatosis: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Spiliotis, John
    Kopanakis, Nikolaos
    Prodromidou, Anastasia
    Raptis, Apostolos
    Farmakis, Dimitrios
    Efstathiou, Elias
    SURGICAL INNOVATION, 2021, 28 (03) : 394 - 395
  • [49] Comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma’
    S C-H Kao
    N van Zandwijk
    S Clarke
    British Journal of Cancer, 2014, 111 : 2376 - 2376
  • [50] Comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'
    Kao, S. C-H
    van Zandwijk, N.
    Clarke, S.
    BRITISH JOURNAL OF CANCER, 2014, 111 (12) : 2376 - 2376
12345